128 related articles for article (PubMed ID: 38355400)
1. Synthesis and Evaluation of Natural and Unnatural Tetrahydrocannabiorcol for Its Potential Use in Neuropathologies.
Anand R; Anand LK; Rashid N; Painuli R; Malik F; Singh PP
J Nat Prod; 2024 Feb; 87(2):167-175. PubMed ID: 38355400
[TBL] [Abstract][Full Text] [Related]
2. Δ⁹-tetrahydrocannabinol (Δ⁹-THC) exerts a direct neuroprotective effect in a human cell culture model of Parkinson's disease.
Carroll CB; Zeissler ML; Hanemann CO; Zajicek JP
Neuropathol Appl Neurobiol; 2012 Oct; 38(6):535-47. PubMed ID: 22236282
[TBL] [Abstract][Full Text] [Related]
3. Δ
Anchesi I; Schepici G; Chiricosta L; Gugliandolo A; Salamone S; Caprioglio D; Pollastro F; Mazzon E
Int J Mol Sci; 2023 May; 24(11):. PubMed ID: 37298437
[TBL] [Abstract][Full Text] [Related]
4. Delta-9-tetrahydrocannabinol protects against MPP+ toxicity in SH-SY5Y cells by restoring proteins involved in mitochondrial biogenesis.
Zeissler ML; Eastwood J; McCorry K; Hanemann CO; Zajicek JP; Carroll CB
Oncotarget; 2016 Jul; 7(29):46603-46614. PubMed ID: 27366949
[TBL] [Abstract][Full Text] [Related]
5. Isolation and Characterization of Impurities in Commercially Marketed Δ
Radwan MM; Wanas AS; Gul W; Ibrahim EA; ElSohly MA
J Nat Prod; 2023 Apr; 86(4):822-829. PubMed ID: 36827690
[TBL] [Abstract][Full Text] [Related]
6. Δ
Schafroth MA; Mazzoccanti G; Reynoso-Moreno I; Erni R; Pollastro F; Caprioglio D; Botta B; Allegrone G; Grassi G; Chicca A; Gasparrini F; Gertsch J; Carreira EM; Appendino G
J Nat Prod; 2021 Sep; 84(9):2502-2510. PubMed ID: 34304557
[TBL] [Abstract][Full Text] [Related]
7. Administration of Δ
Song S; Kong X; Wang B; Sanchez-Ramos J
Cannabis Cannabinoid Res; 2022 Aug; 7(4):424-435. PubMed ID: 34747647
[No Abstract] [Full Text] [Related]
8. Tau protein after delta-9-tetrahydrocannabinol in a human neuroblastoma cell line.
Lew GM
Gen Pharmacol; 1996 Oct; 27(7):1141-3. PubMed ID: 8981058
[TBL] [Abstract][Full Text] [Related]
9. delta-9-Tetrahydrocannabinol: effect on macromolecular synthesis in human and other mammalian cells.
Blevins RD; Regan JD
Arch Toxicol; 1976 Mar; 35(2):127-35. PubMed ID: 947311
[TBL] [Abstract][Full Text] [Related]
10. Investigation of phase II metabolism of 11-hydroxy-Δ-9-tetrahydrocannabinol and metabolite verification by chemical synthesis of 11-hydroxy-Δ-9-tetrahydrocannabinol-glucuronide.
Hassenberg C; Clausen F; Hoffmann G; Studer A; Schürenkamp J
Int J Legal Med; 2020 Nov; 134(6):2105-2119. PubMed ID: 32808050
[TBL] [Abstract][Full Text] [Related]
11. Δ9-tetrahydrocannabinol and its major metabolite Δ9-tetrahydrocannabinol-11-oic acid as 15-lipoxygenase inhibitors.
Takeda S; Jiang R; Aramaki H; Imoto M; Toda A; Eyanagi R; Amamoto T; Yamamoto I; Watanabe K
J Pharm Sci; 2011 Mar; 100(3):1206-11. PubMed ID: 20891010
[TBL] [Abstract][Full Text] [Related]
12. Effects of acute and subchronic delta 9-tetrahydrocannabinol administration on the plasma catecholamine, beta-endorphin, and corticosterone levels and splenic natural killer cell activity in rats.
Patel V; Borysenko M; Kumar MS; Millard WJ
Proc Soc Exp Biol Med; 1985 Nov; 180(2):400-4. PubMed ID: 2996013
[TBL] [Abstract][Full Text] [Related]
13. One-pot heterogeneous synthesis of Δ(3)-tetrahydrocannabinol analogues and xanthenes showing differential binding to CB(1) and CB(2) receptors.
Rosati O; Messina F; Pelosi A; Curini M; Petrucci V; Gertsch J; Chicca A
Eur J Med Chem; 2014 Oct; 85():77-86. PubMed ID: 25072877
[TBL] [Abstract][Full Text] [Related]
14. NTP Toxicology and Carcinogenesis Studies of 1-Trans-Delta(9)-Tetrahydrocannabinol (CAS No. 1972-08-3) in F344 Rats and B6C3F1 Mice (Gavage Studies).
National Toxicology Program
Natl Toxicol Program Tech Rep Ser; 1996 Nov; 446():1-317. PubMed ID: 12594529
[TBL] [Abstract][Full Text] [Related]
15. Discriminative stimulus- and open-field effects of the enantiomers of 11-hydroxy-delta-8-tetrahydrocannabinol in pigeons and gerbils.
Järbe TU; Mechoulam R; Zahalka J
Pharmacol Biochem Behav; 1994 Jan; 47(1):113-9. PubMed ID: 8115412
[TBL] [Abstract][Full Text] [Related]
16. Functional effects of synthetic cannabinoids versus Δ
Schreiber S; Bader M; Lenchinski T; Meningher I; Rubovitch V; Katz Y; Cohen E; Gabet Y; Rotenberg M; Wolf EU; Pick CG
Addict Biol; 2019 May; 24(3):414-425. PubMed ID: 29423994
[TBL] [Abstract][Full Text] [Related]
17. Delta9-tetrahydrocannabinol (Delta9-THC) prevents cerebral infarction via hypothalamic-independent hypothermia.
Hayakawa K; Mishima K; Nozako M; Hazekawa M; Ogata A; Fujioka M; Harada K; Mishima S; Orito K; Egashira N; Iwasaki K; Fujiwara M
Life Sci; 2007 Mar; 80(16):1466-71. PubMed ID: 17289082
[TBL] [Abstract][Full Text] [Related]
18. Tolerance to the effect of delta1-tetrahydrocannabinol on corticosterone levels in mouse plasma produced by repeated administration of cannabis extract or delta1-tetrahydrocannabinol.
Pertwee RG
Br J Pharmacol; 1974 Jul; 51(3):391-7. PubMed ID: 4451752
[TBL] [Abstract][Full Text] [Related]
19. Dark Classics in Chemical Neuroscience: Δ
Banister SD; Arnold JC; Connor M; Glass M; McGregor IS
ACS Chem Neurosci; 2019 May; 10(5):2160-2175. PubMed ID: 30689342
[TBL] [Abstract][Full Text] [Related]
20. Preliminary evidence of cannabinoid effects on brain-derived neurotrophic factor (BDNF) levels in humans.
D'Souza DC; Pittman B; Perry E; Simen A
Psychopharmacology (Berl); 2009 Mar; 202(4):569-78. PubMed ID: 18807247
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
